“…Early diagnosis of ESA can improve the management of pregnant women, reduce the risk of miscarriage, prevent related complications, and carefully monitor ESA and pregnancy progression. 11 , 12 Serum β‐Human Chorionic Gonadotropin (β‐HCG) has been widely used in early pregnancy assessment, 13 However, it has been suggested that serum β-hCG is moderately predictive of ESA (AUC = 0.748, specificity = 71.13 %, sensitivity = 67.71 %). 14 Therefore, there is an urgent need to find better diagnostic biomarkers associated with this pregnancy complication.…”